PolyPeptide Group AG
SWX-PPGN
Company Overview
PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. It engages in manufacturing custom research grade peptides; and developing neoantigen peptide to support personalized cancer therapies. The company is also involved in manufacturing peptides for commercially approved peptide therapeutics. In addition, it manufactures peptide-based generics for human and veterinary markets; and cosmetic peptides. Further, the company offers regulatory affair support services. The company was founded in 1952 and is headquartered in Zug, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.
Name
PolyPeptide Group AG
CEO
Juan Jose Gonzalez
Website
www.polypeptide.com
Sector
Life Sciences Tools and Services
Year Founded
1952
Company Statistics
Profile
Market Cap
—
EV
—
Shares Out
—
Revenue
—
Employees
—
Margins
Gross
—
EBITDA
—
Operating
—
Pre-Tax
—
Net
—
FCF
—
Returns (5Yr Avg)
ROA
—
ROTA
—
ROE
—
ROCE
—
ROIC
—
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
—
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
—
Net Debt
—
Debt/Equity
—
EBIT/Interest
—
Growth (CAGR)
Rev 3Yr
—
Rev 5Yr
—
Rev 10Yr
—
Dil EPS 3Yr
—
Dil EPS 5Yr
—
Dil EPS 10Yr
—
Rev Fwd 2Yr
—
EBITDA Fwd 2Yr
—
EPS Fwd 2Yr
—
EPS LT Growth Est
—
Dividends
Yield
—
Payout
—
DPS
—
DPS Growth 3Yr
—
DPS Growth 5Yr
—
DPS Growth 10Yr
—
DPS Growth Fwd 2Yr
—